BOTH ENGINEERING TECHNOLOGY CO.(601133)

Search documents
柏诚股份:关于2023年半年度利润分配预案的公告
2023-08-24 08:38
柏诚系统科技股份有限公司 证券代码:601133 证券简称:柏诚股份 公告编号:2023-031 公司 2023 年上半年合并报表中归属于上市公司股东的净利润 92,826,088.55 元,母公司 2023 年上半年度实现净利润 91,749,937.75 元,截至 2023 年 6 月 30 日,母公司累计可供分配利润 704,831,243.23 元(2023 年半年度财务数据未经审 计)。 本次利润分配预案为: 关于 2023 年半年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 每股分配比例:每 10 股派发现金红利 0.5 元(含税)。 本次利润分配以实施权益分派股权登记日登记的总股本为基数,具体日 期将在权益分派实施公告中明确。 在实施权益分派的股权登记日前公司总股本发生变动的,拟维持每股分 配比例不变,相应调整分配总额。 本次利润分配预案尚需提交公司股东大会审议。 一、利润分配预案内容 1、公司拟向全体股东每 10 股派发现金红利 0.5 元(含税)。截至 2023 年 8 ...
柏诚股份:柏诚系统科技股份有限公司关于召开2022年度暨2023年第一季度业绩说明会的公告
2023-05-22 10:08
证券代码:601133 证券简称:柏诚股份 公告编号:2023-015 柏诚系统科技股份有限公司 关于召开 2022 年度暨 2023 年第一季度业绩说明会的 公告 柏诚系统科技股份有限公司(以下简称"公司")已于 2023 年 4 月 27 日发 布公司 2022 年年度报告和 2023 年第一季度报告,为便于广大投资者更全面深 入地了解公司 2022 年度及 2023 年第一季度经营成果、财务状况,公司计划于 2023 年 05 月 31 日上午 10:00-11:00 举行 2022 年度暨 2023 年第一季度业绩说明 会,就投资者关心的问题进行交流。 一、说明会类型 1 会议召开时间:2023 年 05 月 31 日(星期三)上午 10:00-11:00。 会 议 召 开 地 点 : 上 海 证 券 交 易 所 上 证 路 演 中 心 ( 网 址 : http://roadshow.sseinfo.com/)。 会议召开方式:上证路演中心网络互动。 投资者可于 2023 年 05 月 24 日(星期三)至 05 月 30 日(星期二)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过 ...
柏诚股份(601133) - 2023 Q1 - 季度财报
2023-04-26 16:00
Financial Performance - The company's operating revenue for Q1 2023 was ¥542,240,460.06, representing a decrease of 7.29% compared to the same period last year[5] - The net profit attributable to shareholders for Q1 2023 was ¥40,408,932.10, down by 5.80% year-on-year[5] - The basic earnings per share for the period was ¥0.10, reflecting a decline of 9.09% compared to the previous year[6] - Total revenue for Q1 2023 was CNY 542,240,460.06, a decrease of 7.3% compared to CNY 584,893,631.42 in Q1 2022[16] - Net profit for Q1 2023 was CNY 40,408,932.10, a decline of 5.8% from CNY 42,897,796.33 in Q1 2022[17] - Total comprehensive income for Q1 2023 was CNY 40,207,488.24, a decrease from CNY 42,829,566.90 in Q1 2022, reflecting a decline of approximately 6.1%[18] - Basic and diluted earnings per share for Q1 2023 were both CNY 0.10, down from CNY 0.11 in Q1 2022, representing a decrease of about 9.1%[18] Assets and Liabilities - The total assets at the end of Q1 2023 amounted to ¥2,633,002,994.01, a decrease of 9.57% from the end of the previous year[6] - Cash and cash equivalents decreased to CNY 436,911,568.88 from CNY 785,828,595.81, representing a decline of 44.4%[12] - Accounts receivable decreased to CNY 369,374,497.28 from CNY 588,409,090.36, a reduction of 37.3%[12] - Inventory decreased to CNY 123,329,861.04 from CNY 140,459,503.55, a decrease of 12.2%[12] - Total assets decreased to CNY 2,633,002,994.01 from CNY 2,911,527,556.07, a decline of 9.6%[13] - Total liabilities decreased to CNY 1,298,416,981.35 from CNY 1,618,456,165.23, a reduction of 19.8%[14] - Shareholders' equity totaled approximately $1.29 billion, with retained earnings at about $709.65 million[26] Cash Flow - The net cash flow from operating activities was negative at -¥267,768,824.86, indicating a significant cash outflow[5] - Cash inflows from operating activities totaled CNY 601,384,179.13 in Q1 2023, compared to CNY 639,545,932.23 in Q1 2022, indicating a decline of approximately 5.9%[20] - Cash outflows from operating activities amounted to CNY 869,153,003.99 in Q1 2023, down from CNY 923,567,018.37 in Q1 2022, a decrease of about 5.9%[21] - Cash flow from investing activities showed a net outflow of CNY 73,855,215.97 in Q1 2023, compared to a net outflow of CNY 27,501,570.98 in Q1 2022, indicating a worsening of cash flow by approximately 168.5%[21] - Cash flow from financing activities resulted in a net outflow of CNY 31,262,433.92 in Q1 2023, contrasting with a net inflow of CNY 33,772,342.16 in Q1 2022[21] - The ending cash and cash equivalents balance for Q1 2023 was CNY 298,553,807.16, a decrease from CNY 671,495,202.76 at the beginning of the period[21] - The company reported a significant decrease in cash received from the sale of goods and services, totaling CNY 600,830,006.02 in Q1 2023, down from CNY 639,110,079.89 in Q1 2022, a decline of approximately 6.0%[20] Operational Efficiency - Total operating costs for Q1 2023 were CNY 490,599,399.12, down 10% from CNY 545,018,208.68 in Q1 2022[16] - The company reported a decrease in gross profit margin, reflecting challenges in maintaining profitability amid rising costs[17] - The weighted average return on equity for Q1 2023 was 3.08%, down by 1.05 percentage points year-on-year[6] Research and Development - Research and development expenses increased to CNY 2,918,835.31 from CNY 1,927,269.39, an increase of 51.5%[17] Corporate Developments - The company has not disclosed any new product developments or market expansion strategies in this report[11] - There are no significant mergers or acquisitions reported during this quarter[11] - The company implemented new accounting standards starting January 1, 2023, which may affect the financial reporting and presentation of financial statements[22]
柏诚股份(601133) - 2022 Q4 - 年度财报
2023-04-26 16:00
Financial Performance - The company achieved a revenue of 50 billion RMB in 2021, positioning it among the top 500 enterprises globally[13]. - In 2022, the company's operating revenue reached approximately CNY 2.75 billion, a slight increase of 0.33% compared to CNY 2.74 billion in 2021[25]. - The net profit attributable to shareholders was approximately CNY 250.85 million, representing a significant increase of 65.18% from CNY 151.86 million in 2021[25]. - The basic earnings per share (EPS) for 2022 was CNY 0.64, up 64.10% from CNY 0.39 in 2021[25]. - The weighted average return on equity (ROE) improved to 21.55%, an increase of 5.93 percentage points from 15.62% in 2021[25]. - The net cash flow from operating activities was approximately CNY 217.09 million, reflecting a 29.02% increase from CNY 168.26 million in 2021[25]. - The total assets at the end of 2022 were approximately CNY 2.91 billion, an 18.17% increase from CNY 2.46 billion at the end of 2021[25]. - The net assets attributable to shareholders increased to approximately CNY 1.29 billion, a 24.89% rise from CNY 1.04 billion in 2021[25]. - The company reported a non-recurring gain of CNY 13.32 million from the disposal of non-current assets in 2022[29]. - The company experienced a quarterly revenue increase, with Q4 2022 revenue reaching approximately CNY 775.88 million, up from CNY 688.73 million in Q3 2022[27]. Dividend Policy - The company plans to distribute a cash dividend of 1.45 CNY per 10 shares, totaling approximately 75.76 million CNY (including tax) based on a total share capital of 52.25 million shares[6]. - The company’s cash dividend policy stipulates that at least 10% of the distributable profit must be distributed as cash dividends each year[175]. - The company aims for a minimum of 80% cash dividend distribution when in a mature stage without major capital expenditures[175]. - The company plans to distribute a cash dividend of 1.45 RMB per 10 shares, totaling 75,762,500 RMB, which represents 30.20% of the net profit attributable to shareholders for the year 2022[178]. - The total share capital as of April 26, 2023, is 52,250,000 shares, which will be the basis for the dividend distribution[178]. - No capital reserve fund will be converted into share capital during this distribution[178]. Corporate Governance - The board of directors has ensured the authenticity, accuracy, and completeness of the annual report[4]. - The company has received a standard unqualified audit report from Rongcheng Accounting Firm[5]. - The company has implemented strict internal control measures and governance practices, ensuring compliance with relevant laws and regulations[184]. - The company has established a framework for managing shareholder actions to maintain control and stability post-IPO[197]. - The commitments are designed to protect the interests of minority shareholders and ensure compliance with regulatory requirements[199]. - The company has established a performance evaluation system for senior management, which effectively incentivizes them to enhance management capabilities and fulfill company objectives[183]. Market Position and Strategy - The company is committed to expanding its market presence in the semiconductor and display technology sectors[14]. - Future strategies include enhancing R&D capabilities and exploring potential mergers and acquisitions to strengthen market position[14]. - The company is well-positioned to capitalize on the increasing cleanroom demand driven by the rapid development of strategic emerging industries such as semiconductors and biomedicine[42]. - The company aims to enhance its core EPC capabilities and develop a unique EPC service capacity in emerging industries such as semiconductors and life sciences[133]. - The company plans to expand its market presence in Southwest, Northwest, and South China, while gradually developing overseas business[134]. Research and Development - The company is involved in the development of FinFET technology, which is crucial for advanced semiconductor manufacturing[14]. - The company is focusing on the development of Low Temperature Poly-silicon (LTPS) technology, which enhances resolution, response speed, brightness, and electron mobility in displays[16]. - The company has engaged in research and development of new display technologies, including Mini-LED and Micro-LED, to enhance display performance and reduce production costs[15]. - Research and development expenses rose by 52.76% to CNY 9,701,904.12, indicating increased investment in innovation[99]. - The company has obtained 101 utility model patents and 2 invention patents, showcasing its commitment to technological innovation[94]. Industry Trends - The semiconductor industry is projected to grow significantly, with a focus on high-level clean environments for manufacturing[14]. - The cleanroom market in China is projected to reach CNY 358.65 billion by 2026, with a compound annual growth rate (CAGR) of 15.01% from 2016 to 2026[43]. - The global semiconductor market reached USD 555.89 billion in 2021, with a year-on-year growth of 26.2%, and is expected to grow to USD 601.49 billion in 2022[45]. - The cleanroom industry is anticipated to see sustained demand growth due to the ongoing upgrades and technological innovations in semiconductor and photovoltaic manufacturing processes[50][51][52]. - The global biopharmaceutical market size reached approximately $336.6 billion in 2021, with a projected growth to 55% of the top 100 drug sales by 2026[63]. Client Relationships and Market Competition - The company has established long-term cooperative relationships with renowned clients such as BOE, Samsung, and BeiGene, indicating strong client retention and project continuity[1]. - The company primarily serves leading enterprises in the semiconductor, new display, life sciences, and health sectors, maintaining long-term stable partnerships with major clients[84]. - The cleanroom market is characterized by intense price competition, particularly in the low-end market, while few companies can provide high-level cleanroom system integration services[81]. - The company has established strong competitive advantages through quality service and rapid response capabilities, serving high-investment clients with stringent cleanroom requirements[86]. Employee and Management Structure - The company has a stable management team and will focus on talent development aligned with strategic needs[136]. - The company has a total of 919 employees, with 869 in the parent company and 50 in major subsidiaries[170]. - The employee composition includes 646 project personnel, 202 management personnel, 42 sales personnel, and 29 R&D personnel[170]. - The company has a strong commitment to human resources, with a focus on employee development and retention strategies[156]. Environmental and Social Responsibility - The company has achieved ISO14001 environmental management system certification, indicating its commitment to environmental protection and compliance with regulations[188]. - The company has invested 200,000 RMB in social responsibility projects, specifically in charitable funds for elderly assistance and educational support[190].
柏诚股份:柏诚股份首次公开发行股票主板上市公告书
2023-04-06 11:22
柏诚系统科技股份有限公司 上市公告书 股票简称:柏诚股份 股票代码:601133 柏诚系统科技股份有限公司 BOTH ENGINEERING TECHNOLOGY CO.,LTD. (无锡市隐秀路 800-2101) 首次公开发行股票主板 上市公告书 保荐人(主承销商) (广东省深圳市福田区中心三路 8 号卓越时代广场(二期)北座) 二〇二三年四月七日 1 柏诚系统科技股份有限公司 上市公告书 特别提示 柏诚系统科技股份有限公司(以下简称"柏诚股份"、"发行人"、"公司"、 "本公司")股票将于 2023 年 4 月 10 日在上海证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素,在新 股上市初期切忌盲目跟风"炒新",应当审慎决策、理性投资。 2 柏诚系统科技股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明 本公司及全体董事、监事、高级管理人员保证上市公告书所披露信息的真实、 准确、完整,承诺上市公告书不存在虚假记载、误导性陈述或者重大遗漏,并依 法承担法律责任; 上海证券交易所、有关政府机关对本公司股票上市及有关事项的意见,均不 表明对本公司的任何保证; 本 ...
柏诚股份:柏诚股份首次公开发行股票并在主板上市招股说明书
2023-04-03 11:25
招股说明书 柏诚系统科技股份有限公司 BOTH ENGINEERING TECHNOLOGY CO.,LTD. (无锡市隐秀路 800-2101) 首次公开发行股票并在主板上市 招股说明书 保荐人(主承销商) (广东省深圳市福田区中心三路 8 号卓越时代广场(二期)北座) 1-1-1 招股说明书 发行人声明 中国证监会、交易所对本次发行所作的任何决定或意见,均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证,也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》的规定,股票依法发行后,发行人经营与收益的变化,由发 行人自行负责;投资者自主判断发行人的投资价值,自主作出投资决策,自行承 担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-2 招股说明书 本次发行概况 | 发行股票类型 | 人民币普通股(A 股) | | | | | --- | --- | --- | --- | --- | | 发行股数 | 本次发行股票的数量为 13,000.00 万股,占本次发行后总股本比 | ...
柏诚股份:柏诚股份首次公开发行股票并在主板上市发行结果公告
2023-04-03 11:17
柏诚系统科技股份有限公司 首次公开发行股票并在主板上市 发行结果公告 保荐人(主承销商):中信证券股份有限公司 柏诚系统科技股份有限公司(以下简称"发行人"或"柏诚股份")首次公 开发行人民币普通股(A 股)并在主板上市(以下简称"本次发行")的申请于 2023 年 3 月 13 日经上海证券交易所(以下简称"上交所")上市审核委员会审 议通过,并已经中国证券监督管理委员会同意注册(证监许可〔2023〕579 号文)。 发行人的股票简称为"柏诚股份",扩位简称为"柏诚系统股份公司",股票代 码为"601133"。 中信证券股份有限公司(以下简称"中信证券"或"保荐人(主承销商)") 担任本次发行的保荐人(主承销商)。 本次发行采用网下向符合条件的投资者询价配售(以下简称"网下发行") 与网上向持有上海市场非限售 A 股股份和非限售存托凭证市值的社会公众投资 者定价发行(以下简称"网上发行")相结合的方式进行。 保荐人(主承销商)根据上交所和中国证券登记结算有限公司上海分公司提 供的数据,对本次网上、网下发行的新股认购情况进行了统计,结果如下: 发行人与保荐人(主承销商)根据初步询价结果,综合考虑发行人基本面、 ...
柏诚股份:柏诚股份首次公开发行股票并在主板上市发行公告
2023-03-27 11:14
柏诚系统科技股份有限公司 首次公开发行股票并在主板上市 发行公告 保荐人(主承销商):中信证券股份有限公司 重要提示 柏诚系统科技股份有限公司(以下简称"柏诚股份"、"发行人"或"公司") 根据中国证券监督管理委员会(以下简称"中国证监会"或"证监会")颁布的《证 券发行与承销管理办法》(证监会令〔第 208 号〕)(以下简称"《管理办法》")、 《首次公开发行股票注册管理办法》(证监会令〔第 205 号〕),上海证券交易所(以 下简称"上交所")颁布的《上海证券交易所首次公开发行证券发行与承销业务实施 细则》(上证发〔2023〕33 号)(以下简称"《首发承销细则》")、《上海市场 首次公开发行股票网上发行实施细则(2023 年修订)》(上证发〔2023〕35 号)(以 下简称"《网上发行实施细则》")、《上海市场首次公开发行股票网下发行实施细 则(2023 年修订)》(上证发〔2023〕36 号),中国证券业协会(以下简称"证券 业协会")颁布的《首次公开发行证券承销业务规则》(中证协发〔2023〕18 号) (以下简称"《承销业务规则》")、《首次公开发行证券网下投资者管理规则》(中 证协发〔2023〕 ...
柏诚股份:柏诚股份首次公开发行股票并在主板上市招股意向书提示性公告
2023-03-20 11:52
柏诚系统科技股份有限公司 首次公开发行股票并在主板上市 招股意向书提示性公告 保荐人(主承销商):中信证券股份有限公司 扫描二维码查阅公告全文 柏诚系统科技股份有限公司(以下简称"柏诚股份"、"发行人"或"公 司")首次公开发行股票并在主板上市的申请已经上海证券交易所(以下简称 "上交所")上市审核委员会审议通过,并已经中国证券监督管理委员会(以下 简称"中国证监会")证监许可〔2023〕579 号文同意注册。《柏诚系统科技股 份有限公司首次公开发行股票并在主板上市招股意向书》及附录在上海证券交易 所网站(www.sse.com.cn)和符合中国证监会规定条件网站(中证网,网址 www.cs.com.cn;中国证券网,网址 www.cnstock.com;证券时报网,网址 www.stcn.com;证券日报网,网址 www.zqrb.cn)披露,并置备于发行人、上交 所、本次发行保荐人(主承销商)中信证券股份有限公司的住所,供公众查阅。 敬请投资者重点关注本次发行流程、网上网下申购及缴款、弃购股份处理等 方面,并认真阅读同日披露于上海证券交易所网站和符合中国证监会规定条件网 站上的《柏诚系统科技股份有限公司首 ...
柏诚股份:柏诚股份首次公开发行股票并在主板上市招股意向书
2023-03-20 11:51
招股意向书 柏诚系统科技股份有限公司 BOTH ENGINEERING TECHNOLOGY CO.,LTD. (无锡市隐秀路 800-2101) 首次公开发行股票并在主板上市 招股意向书 保荐人(主承销商) (广东省深圳市福田区中心三路 8 号卓越时代广场(二期)北座) 1-1-1 招股意向书 发行人声明 中国证监会、交易所对本次发行所作的任何决定或意见,均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证,也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》的规定,股票依法发行后,发行人经营与收益的变化,由发 行人自行负责;投资者自主判断发行人的投资价值,自主作出投资决策,自行承 担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-2 招股意向书 本次发行概况 | 发行股票类型 | 人民币普通股(A 股) | | | | | --- | --- | --- | --- | --- | | 发行股数 | 本次发行股票的数量为 13,000.00 万股,占本次发行后总股本比 | ...